Cystic Fibrosis Foundation Therapeutics: Utilizing the CFFT Biorepository to Identify & Validate CF Biomarkers – letter of intent

After successful LOI that outlined scientific plan & required biospecimens and clinical data needed for aims, invited applicants may address these sample topics or others: mechanisms/predictors of CFTR modulator responsiveness / identification/validation of novel biomarkers, those that accurately reflect disease severity, those that identify/predict/reflect severity or risk profile, or those enabling understanding of airways microbiology in the CF lung, those that are inflammatory responses in CF / development/application of novel technologies useful for biomarker identification/validation. $100,000 per yr/2 years.
http://www.cff.org/research/ForResearchers/ResearchTools/CFFTBiorepository/